US and Canada
Pharma, biotech and radiopharma news
Gilead to Spend $1.275B on PepStar's Phase 1 Oral IBD Drug
Genmab's Rina-S Beats Chemo in Ovarian Cancer, Cuts Death Risk 57%
Merck, Moderna Vaccine Combo Cuts Melanoma Relapse or Death Risk 42%
FDA Faults Baxter Oversight, Cites 4 Failings at Illinois Drug Plant
The Monday digest
Top pharma news and new jobs in the US and Canada. One email a week.
Free. By signing up you agree to this: Yes, email me the Monday news digest (pharma and biotech news and jobs) from PharmoniQ (info@pharmoniq.com). I can unsubscribe at any time.
AI Outsourcing Navigator
Find a pharma partner
Describe what you need. The Navigator suggests matching CDMOs, CROs and service providers, and we can introduce you.
Partner Directory
482 companies
Service providers across the US and Canada, with capabilities and certifications.
Radiopharma
All radiopharma news →Latest jobs
See all jobs →Browse jobs
By role
By city
More news
All news →Roivant's Brepocitinib Wins Two Phase 3 Uveitis Trials
Merck KGaA to Buy Silence Therapeutics for $1.3B in Cash
FDA Approves GSK's Hibsago for Chronic Hepatitis B
EyePoint Cuts 53% of Staff After Eye Drug's Second Phase 3 Miss
Disc's Bitopertin Hits All Phase 3 Goals in Rare Light Disorder
Roche Pays Hansoh $400M Upfront for New Cancer ADC Programs
FDA Approves Genentech's Enspryng for Thyroid Eye Disease
Gilead Pays Vir $90M Upfront in Deal Worth Up to $1.9B
China Moves to Ban Foreign Buyouts of Key Biotech Platforms
GSK Plans $800M Biologics Manufacturing Hub in Pennsylvania
Admilparant Meets Phase 3 Endpoint in IPF Trial
Deals & partnerships
All →From the blog
All →10 min read
Canada's Drug Reliance Order: What It Changes for Sponsors
11 min read
Licensing Drugs From China: Deal Terms and the New U.S. Risks
11 min read
Scaling Cell and Gene Therapy Manufacturing to Industrial Scale
11 min read
The Future of Personalized Supplement Recommendations: AI, Genomics, and Precision Nutrition